Craft

Trinity Biotech

Stock Price

$2

2024-10-29

Market Capitalization

$19.1 M

2024-10-29

Revenue

$61.6 M

FY, 2024

Trinity Biotech Summary

Company Summary

Overview
Trinity Biotech is a company that specializes in the development, manufacture, and marketing of diagnostic test kits. They are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune disorders, cardiac arrest, hemoglobin disorders, and diabetes. The company also provides raw materials to the life sciences industry.
Type
Public
Status
Active
Founded
1992
HQ
Bray, IE | view all locations
Website
http://www.trinitybiotech.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Ronan O'Caoimh

    Ronan O'Caoimh, Chairman and Chief Executive Officer

    • Jim Walsh

      Jim Walsh, Executive Director

      • John Gillard, Chief Financial Officer & Executive Director

        • Kevin Tansley, Chief Financial Officer

          LocationsView all

          2 locations detected

          • Bray, WW HQ

            Ireland

            Industrial Development Agency Business Park, Southern Cross Rd, Irishtown

          • Jamestown, NY

            United States

            2823 Girts Rd

          Trinity Biotech Financials

          Summary Financials

          Revenue (Q3, 2025)
          $14.3M
          Gross profit (Q3, 2025)
          $7.4M
          Net income (Q3, 2025)
          ($5.1M)
          Cash (Q3, 2025)
          $1.3M
          EBIT (Q3, 2025)
          ($1.0M)
          Enterprise value
          $135.0M

          Footer menu